Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial Purpose: To compare the detection of human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback